Qingchang decoction retention enema may induce clinical and mucosal remission in left-sided ulcerative colitis: A case report
- PMID: 35582052
- PMCID: PMC9048555
- DOI: 10.12998/wjcc.v10.i11.3573
Qingchang decoction retention enema may induce clinical and mucosal remission in left-sided ulcerative colitis: A case report
Abstract
Background: Ulcerative colitis (UC) is a chronic autoimmune disease characterized by relapsing-remitting abdominal pain, diarrhea, mucopurulent discharge and rectal bleeding. To date, the etiology of the disease remains unknown; therefore, medical therapy is not yet available. Left-sided UC is mainly treated with oral and topical mesalazine. However, due to its modest clinical effect, endoscopic mucosal remission is not achieved in all patients.
Case summary: A 44-year-old man presented to Longhua Hospital with a history of left-sided UC for more than 6 years and slight bloody diarrhea over time. Endoscopy suggested hyperemia, edema, and erosive mucosa involving the rectum and sigmoid colon. The Traditional Chinese medicine Qingchang decoction (QCD) enema treatment was initiated once a day combined with a previous standard dose of mesalazine for 8 wk, and rectal bleeding ceased after 4 wk of treatment. Another QCD enema treatment was provided after symptom relapse due to drug withdrawal for nearly 6 mo. At the 2-mo follow-up, the colonoscopy results indicated mucosal healing with no erosion or ulcers.
Conclusion: The Chinese formula QCD retention enema represents a potential treatment for left-sided UC with predominant rectal bleeding to achieve clinical and mucosal remission.
Keywords: Case report; Chinese formulas; Qingchang decoction enema; Qingchang suppository; Ulcerative colitis.
©The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved.
Conflict of interest statement
Conflict-of-interest statement: The authors declare that they have no conflict of interest.
Figures


References
-
- Inflammatory Bowel Disease Group; Chinese Society of Gastroenterology (CSG), Chinese Medical Association. A consensus view on the diagnosis and treatment of inflammatory bowel disease (IBD) Zhonghua Xiaohua Zazhi. 2018;38:292–311.
-
- Chinese inflammatory bowel disease cooperative group. Retrospective analysis of 3100 hospitalized cases of ulcerative colitis. Zhonghua Xiaohua Zazhi. 2006;26:368–372.
-
- Harbord M, Eliakim R, Bettenworth D, Karmiris K, Katsanos K, Kopylov U, Kucharzik T, Molnár T, Raine T, Sebastian S, de Sousa HT, Dignass A, Carbonnel F European Crohn’s and Colitis Organisation [ECCO] Third European Evidence-based Consensus on Diagnosis and Management of Ulcerative Colitis. Part 2: Current Management. J Crohns Colitis. 2017;11:769–784. - PubMed
-
- Rubin DT, Ananthakrishnan AN, Siegel CA, Sauer BG, Long MD. ACG Clinical Guideline: Ulcerative Colitis in Adults. Am J Gastroenterol. 2019;114:384–413. - PubMed
Publication types
LinkOut - more resources
Full Text Sources